CCM
GILD icon

Catalio Capital Management’s Gilead Sciences GILD Stock Holding History

Catalio Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8M Sell
163,905
-125,407
-43% -$17.6M 4.77% 6
2025
Q4 		$35.5M Buy
+289,312
New +$35.2M 6.28% 1
2025
Q3 		– Sell
-226,875
Closed -$25.2M – 42
2025
Q2 		$25.2M Buy
+226,875
New +$24.1M 5.27% 7

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Catalio Capital Management's GILD Position: Q1 2026 in Review

Catalio Capital Management reduced its Gilead Sciences (GILD) stake by 43% in Q1 2026, selling an estimated $17.6M and leaving 163,905 shares worth $22.8M. The position accounts for 4.77% of the portfolio, ranked #6.

Catalio Capital Management first reported a position in GILD in Q2 2025 and has held it in 3 quarters since. The position peaked at $35.5M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Catalio Capital Management held 163,905 shares of Gilead Sciences worth $22.8M as of Q1 2026.
  • Catalio Capital Management sold 125,407 Gilead Sciences shares in Q1 2026, an estimated $17.6M.
  • Gilead Sciences made up 4.77% of Catalio Capital Management's portfolio in Q1 2026, its #6 holding.
  • Catalio Capital Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 3 quarters since.
  • Catalio Capital Management's Gilead Sciences position peaked at $35.5M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Catalio Capital Management's 13F filing for Q1 2026, filed 15 May 2026.